Domo, Inc.
NASDAQ:DOMOSoftware - Application
+$0.43 today
- Market cap
- $155.39M
- Beta
- 1.77
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$1.28
Volume 3.18M
Average 1.39M
DOMO Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Domo, Inc.NASDAQ: DOMO
Revenue · Q1 FY2027 · quarter ended Apr 2026
Revenue dips below year-ago levels
Q1 FY2027 revenue of $79.4M fell 0.9% year over year, behind the +0.3% change in trailing-twelve-month revenue. Sequentially, it fell 0.3% from the prior quarter. Over 3 fiscal years it compounded at +1.1% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 1 analysts of $313.02M (-1.8%) for the fiscal year ending Jan 2027, a slowdown from the +0.6% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $79.4M-0.3% QoQ
- Last fiscal yearJan 2026
- $318.86M+0.6% YoY
- LTMApr 2026
- $318.15M+0.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.9% | -2.1% | -1.2 pp |
| 1 year | +0.6% | -1.8% | -2.4 pp |
| 3-year CAGR | +1.1% | -5.7% | -6.8 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2026
- 318.86M USD
- Year-over-year change
- +0.6%
- 4-year CAGR
- +5.4%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 318.86M | +0.6% |
| FY2025 | 2025-01-31 | 317.04M | -0.6% |
| FY2024 | 2024-01-31 | 318.99M | +3.4% |
| FY2023 | 2023-01-31 | 308.65M | +19.6% |
| FY2022 | 2022-01-31 | 257.96M | — |
Revenue vs competitors
How DOMO compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of +0.3% is the 9th highest of 11, against a peer median of +16.0%.
- Over three fiscal years its annual growth of +1.1% compares with a peer median of +17.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $930.94M USD | -11.4% | +2.2% | |
| LTM Mar 2026 | $565.25M USD | +15.2% | -5.3% | |
| LTM Mar 2026 | $469.76M USD | +12.3% | +21.7% | |
| LTM Apr 2026 | $318.15M USD | +0.3% | +1.1% | |
| LTM Mar 2026 | $302.14M USD | +18.8% | -8.4% | |
| LTM Mar 2026 | $248.72M USD | +16.8% | +18.9% | |
| LTM Mar 2026 | $149.89M USD | +13.3% | +19.6% | |
| LTM Mar 2026 | $94.08M USD | +28.4% | +17.5% | |
| LTM Mar 2026 | $40.36M USD | +8712.9% | +115.9% | |
| FY2025 | $530K USD | +80.9% | -58.1% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥0 CNY | -100.0% | — |
| Peer median (excluding DOMO) | — | +16.0% | +17.5% | |
Competitors are the stored peer set for DOMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 257.96M | 308.65M | 318.99M | 317.04M | 318.86M |
| Cost of Revenue | 67.15M | 73.08M | 75.47M | 80.99M | 79.74M |
| Gross Profit | 190.82M | 235.57M | 243.52M | 236.05M | 239.12M |
| Gross Margin | 74.0% | 76.3% | 76.3% | 74.5% | 75.0% |
| Research & Development | 81.03M | 95.09M | 85.05M | 87.9M | 77.19M |
| Selling, General & Admin | 198.26M | 229.35M | 213.35M | 206.83M | 201.03M |
| Operating Expenses | 279.29M | 324.44M | 298.4M | 295.33M | 278.22M |
| Depreciation & Amortization | 5.36M | 5.29M | 6.62M | 9.24M | 28.75M |
| EBITDA | (83.11M) | (82.96M) | (47.51M) | (51.69M) | (28.84M) |
| EBITDA Margin | -32.2% | -26.9% | -14.9% | -16.3% | -9.0% |
| Operating Income | (88.47M) | (88.87M) | (54.88M) | (59.28M) | (39.1M) |
| Operating Margin | -34.3% | -28.8% | -17.2% | -18.7% | -12.3% |
| Interest Income | 13.4M | 15.5M | 0 | 0 | 0 |
| Interest Expense | 14.1M | 15.5M | 0 | 19.8M | 0 |
| Other Income / Expenses | (14.1M) | (15.5M) | (19.43M) | (21.44M) | (18.49M) |
| Income Before Tax | (102.57M) | (104.37M) | (74.31M) | (80.73M) | (57.58M) |
| Pre-Tax Margin | -39.8% | -33.8% | -23.3% | -25.5% | -18.1% |
| Income Tax Expense | (461K) | 1.18M | 1.26M | 1.21M | 1.76M |
| Net Income | (102.11M) | (105.55M) | (75.57M) | (81.94M) | (59.34M) |
| Net Margin | -39.6% | -34.2% | -23.7% | -25.8% | -18.6% |
| EPS (Basic) | (3.19) | (3.10) | (2.10) | (2.13) | (1.45) |
| EPS (Diluted) | (3.19) | (3.10) | (2.10) | (2.13) | (1.45) |
| Weighted Avg Shares | 32.02M | 34.09M | 36.05M | 38.5M | 40.98M |
| Weighted Avg Shares (Diluted) | 32.02M | 34.09M | 36.05M | 38.5M | 40.98M |
Domo, Inc.
NASDAQ:DOMO
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.